ArticleThe Journal of biological chemistry2015

Interleukin-2-inducible T-cell kinase (ITK) targeting by BMS-509744 does not affect cell viability in T-cell prolymphocytic leukemia (T-PLL).

Sabine Dondorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.